Reported Friday, MannKind's Afrezza Data At ADA Highlight Pediatric Safety, Gestational Diabetes Efficacy And AID System Compatibility Following May 2026 FDA Pediatric Approval
MannKind Corp MNKD
$3.96
โฒ +1.02%
(+$0.04)
Open
$4.01
Prev Close
$3.92
Day Range
$3.83 โ $4.02
52W Range
$2.23 โ $6.51
Market Cap
$1.22B
P/E (TTM)
207.62
Beta
1.15
EPS (TTM)
$-0.08
๐ Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2004-07-28 |
| Shares Out. | 308,950,000 |
| Website | mannkindcorp.com/ โ |
| Phone | 18009279800 |
MannKind Corp is a publicly traded company under the ticker symbol MNKD on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
14 analysts (2026-06-01)
